Published:
King Pharmaceuticals to Present at Credit Suisse Healthcare Conference
BRISTOL, Tenn. - (BUSINESS WIRE) - King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a
live webcast of its presentation scheduled for Thursday, November 12,
2009, at 9:00 am Mountain Standard Time (11:00 am Eastern Standard
Time), at the Credit Suisse 2009 Healthcare Conference at the Arizona
Biltmore Hotel in Phoenix, Arizona. The presentation may include a
discussion of the Company's marketed products, pipeline, strategy for
growth, financial results and expectations, and other matters relating
to its business.
Interested persons may access the live webcast via the internet on the
King Pharmaceuticals website at the following link: http://www.kingpharm.com/Investors/Webcasts.cfm.
A replay of the webcast may be accessed at this same link for a period
of not less than 14 days after the live event.
About King Pharmaceuticals, Inc.
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and
acquisitions, of novel branded prescription pharmaceutical products and
technologies that complement the Company's focus in specialty-driven
markets, particularly neuroscience and hospital. King's wholly-owned
subsidiary, Alpharma, Inc., is also a leader in the development,
registration, manufacture and marketing of pharmaceutical products for
food producing animals.
About Forward-looking Statements
This release contains forward-looking statements which reflect
management's current views of future events and operations, including,
but not limited to, statements pertaining to the anticipated webcast of
the Company's presentation on November 12, 2009. These forward-looking
statements involve certain significant risks and uncertainties, and
actual results may differ materially from the forward-looking
statements. An important factor which may cause results to differ is
whether King is able to webcast the presentation on November 12, 2009 as
currently planned. King does not undertake to publicly update or revise
any of its forward-looking statements even if experience or future
changes show that the indicated results or events will not be realized.
EXECUTIVE OFFICES
KING PHARMACEUTICALS, INC.
501 FIFTH STREET, BRISTOL, TENNESSEE 37620
King Pharmaceuticals, Inc.
Jack Howarth, Vice President, Investor
Relations, 908-429-8350
Copyright © 2009, Business Wire, Inc., All rights reserved.
Copyright © 2009, NewsBlaze,
Daily NewsTags: Pharmaceuticals, Business wire, arizona, tennessee, Health
Search News
Daily News
